(Q39723189)

14 September 2017

title

Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice (English)

1 reference

14 September 2017

1 reference

0 references

S-H Ma

1

1 reference

14 September 2017

G G Chen

series ordinal

2

1 reference

14 September 2017

J Yip

series ordinal

3

1 reference

14 September 2017

P B S Lai

series ordinal

4

1 reference

14 September 2017

publication date

25 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

17

1 reference

14 September 2017

issue

7

1 reference

14 September 2017

page(s)

905-912

1 reference

Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Systemic treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Expression and Hypomethylation of α-Fetoprotein Gene in Unicentric and Multicentric Human Hepatocellular Carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Estimation of liver tumor volume using different formulas - an experimental study in rats

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.34

7 January 2021

Identifiers

DOI

10.1038/GT.2010.34

1 reference

Dimensions Publication ID

14 September 2017

1018911534

0 references

1 reference